Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma D Chen, Z Zhao, Z Huang, DC Chen, XX Zhu, YZ Wang, YW Yan, S Tang, ... Bone research 6 (1), 11, 2018 | 121 | 2018 |
Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization Y Jiang, W Ni Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (9 …, 2015 | 62 | 2015 |
Impact of a pharmacy-based transitional care program on hospital readmissions W Ni, D Colayco, C Gowda, B Wearda, J McCombs AMERICAN JOURNAL OF MANAGED CARE 23 (3), 170-176, 2017 | 54 | 2017 |
Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping W Ni, C Le Guiner, G Gernoux, M Penaud-Budloo, P Moullier, RO Snyder Gene therapy 18 (7), 709-718, 2011 | 52 | 2011 |
Reduction of healthcare costs through a transitions-of-care program W Ni, D Colayco, J Hashimoto, K Komoto, C Gowda, B Wearda, ... The Bulletin of the American Society of Hospital Pharmacists 75 (10), 613-621, 2018 | 32 | 2018 |
Budget impact analysis of a pharmacist-provided transition of care program W Ni, D Colayco, J Hashimoto, K Komoto, C Gowda, B Wearda, ... Journal of managed care & specialty pharmacy 24 (2), 90-96, 2018 | 29 | 2018 |
Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis Y Jiang, W Ni, J Wu BMJ open 9 (11), e031186, 2019 | 22 | 2019 |
PCR-based detection of gene transfer vectors: application to gene doping surveillance IC Perez, C Le Guiner, W Ni, J Lyles, P Moullier, RO Snyder Analytical and bioanalytical chemistry 405, 9641-9653, 2013 | 22 | 2013 |
Development and utility of an internal threshold control (ITC) real-time PCR assay for exogenous DNA detection W Ni, C Le Guiner, P Moullier, RO Snyder PLoS One 7 (5), e36461, 2012 | 21 | 2012 |
Performance of unanchored matching-adjusted indirect comparison (MAIC) for the evidence synthesis of single-arm trials with time-to-event outcomes Y Jiang, W Ni BMC medical research methodology 20, 1-9, 2020 | 19 | 2020 |
Impact of supplementary private health insurance on hospitalization and physical examination in China Y Jiang, W Ni China Economic Review 63, 101514, 2020 | 18 | 2020 |
Expected lifetime numbers, risks, and burden of osteoporotic fractures for 50-year old Chinese women: a discrete event simulation incorporating FRAX Y Jiang, W Ni Journal of bone and mineral metabolism 34, 714-722, 2016 | 17 | 2016 |
Cost-effectiveness analysis of Glybera for the treatment of lipoprotein lipase deficiency X Han, W Ni Value in Health 18 (7), A756, 2015 | 16 | 2015 |
Risk selection into supplemental private health insurance in China Y Jiang, W Ni Health Economics Review 9, 1-11, 2019 | 12 | 2019 |
Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model W Ni, Y Jiang Osteoporosis International 28, 529-538, 2017 | 11 | 2017 |
Trends in opioid use following balloon kyphoplasty or vertebroplasty for the treatment of vertebral compression fractures W Ni, C Ricker, M Quinn, N Gasquet, D Janardhanan, CJ Gilligan, ... Osteoporosis International, 1-17, 2022 | 10 | 2022 |
Association between supplemental private health insurance and burden of out-of-pocket healthcare expenditure in China: A novel approach to estimate two-part model with random … Y Jiang, W Ni Risk Management and Healthcare Policy, 323-334, 2020 | 10 | 2020 |
Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection S Xuan, KM Zangwill, W Ni, J Ma, JW Hay Journal of General Internal Medicine 35, 1102-1110, 2020 | 10 | 2020 |
Economic evaluation of the 2016 Chinese guideline and alternative risk thresholds of initiating statin therapy for the management of atherosclerotic cardiovascular disease Y Jiang, W Ni Pharmacoeconomics 37, 943-952, 2019 | 9 | 2019 |
Detection Methods for Target DNA RO Snyder, P Moullier, W Ni, C LeGuiner US Patent App. 13/983,683, 2015 | 9 | 2015 |